Committees

Organising Committee

  • Manuel Narváez Peláez (University of Málaga; IMBRAIN Chair) – Chair · Contact
  • Carlos Diéguez González (University of Santiago de Compostela) – Metabolism and Endocrinology · Contact
  • Dasiel Borroto-Escuela (University of Málaga / IMBRAIN Chair / Karolinska Institutet) – Receptor–Receptor Interactions · Contact
  • Pedro Serrano-Castro (Neurology, HRU Málaga) – Clinical Neurology · Contact
  • Jesús Romero Imbroda (Head of Neurology, Quirón Málaga / IMBRAIN Chair / Medical Imbrain) – CEO. Clinic and Trials · Contact
  • Javier Dionicio (Medical IMBRAIN / IMBRAIN Chair) – Medical Director · Contact
  • Carmen Pérez Enríquez (Medical IMBRAIN / IMBRAIN Chair) · Contact
  • Isabel Moreno Madrid (University of Málaga / IMBRAIN Chair) · Contact
  • Mario Delgado (IPB-CSIC, Spain) – Immunomodulation and Peptides · Contact
  • Yasmina Juarranz Moratilla (Complutense University of Madrid, Spain) – Biomarkers and VIP/PACAP Liaison · Contact

Scientific Committee

Internacional (ISBAP / VIP–PACAP)

  • David Vaudry (Inserm, France) – ISBAP Liaison · Contact
  • Illana Gozes (Tel Aviv University, Israel) – Neurodevelopment and Peptides · Contact
  • Dora Reglődi (University of Pécs, Hungary) – VIP/PACAP Liaison · Contact
  • Joe Pisegna (UCLA, United States) – Gastrointestinal Systems and Neuropeptides · Contact
  • Niels Wierup (Lund University, Sweden) – Metabolism and Biomarkers · Contact
  • Karl-Heinz Herzig (University of Oulu, Finland) – Metabolism Liaison · Contact
  • Seiji Shioda (Shinshu University, Japan) – PACAP/VIP · Contact
  • Erika Pintér (University of Pécs, Hungary) – Pain and TRP Systems · Contact
  • Yoshitatsu Hashimoto (Osaka University, Japan) – Peptide Pharmacology · Contact
  • Barbara Kofler (PMU Salzburg, Austria) – NPY/Galanin · Contact
  • Billy K.C. Chow (University of Hong Kong, Hong Kong) – Peptide Biology and GPCR · Contact
  • Andreas Stengel (University of Tübingen, Germany) – Gut–Brain Peptides · Contact
  • Olga Yashina (Complutense University of Madrid, Spain) – Peptide Chemistry and Biology · Contact
  • Sue Brain (King’s College London, United Kingdom) – Neuropharmacology and Inflammation · Contact
  • Olfa Masmoudi (University of Tunis El Manar, Tunisia) – Neurochemistry and Science Communication · Contact
  • Serguei Fetissov (University of Rouen, France) – Eating Disorders and Peptides · Contact
  • Madhukar Thakur (Thomas Jefferson University, United States) – Radiopharmacy and Translational Research · Contact

Local (Spain)

  • Manuel Narváez Peláez (University of Málaga; IMBRAIN Chair) – Chair · Contact
  • Carlos Diéguez González (University of Santiago de Compostela) – Metabolism and Endocrinology · Contact
  • Dasiel Borroto-Escuela (University of Málaga / Karolinska Institutet) – Receptor–Receptor Interactions · Contact
  • Pedro Serrano-Castro (Neurology, HRU Málaga) – Clinical Neurology · Contact
  • Jesús Romero Imbroda (Head of Neurology, Quirón Málaga / Medical Imbrain) – CEO. Clinic and Trials · Contact
  • Javier Dionicio (Medical IMBRAIN) – Medical Director · Contact
  • Mario Delgado (IPB-CSIC, Spain) – Immunomodulation and Peptides · Contact
  • Yasmina Juarranz Moratilla (Complutense University of Madrid, Spain) – Biomarkers and VIP/PACAP Liaison · Contact